GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Research CompaniesFeaturedAll Members

Stock Research Companies Directory

Search Member by Name
MemberDescription
B. Riley B. Riley'research process is an interactive one where we perform extensive due diligence on companies until the analyst develops the knowledge base and understanding of the company and the industry  (more)
B. Riley & Co B. Riley's distinguished equity and high yield research is the mainstay of the firm, contributing unparalleled value to our institutional and private clients. Our success is based on our history of  (more)
B. Riley Caris B. Riley Caris
Banc of America Sec Integrity, objectivity and originality are cornerstones of the value–added research that we offer to corporate and institutional clients. As thought leaders, our goal is to help clients understand  (more)
Barclays Barclays
Barclays Capital Barclays Capital has assembled a world-class, award-winning team of analysts covering, credit, commodities, economics, emerging markets, equities, fixed income, foreign exchange and market  (more)
Barrington Research As our name implies, research plays a central role in everything we do. Whether we're dealing with sales, trading, investment banking or asset management, insightful research is indispensable in  (more)
Barron's favorite stocks for 2011 The U.S. stock market has logged its second straight year of gains following the crushing losses stocks suffered in 2008. The Standard & Poor's 500 stock index entered the final session of 2010 with  (more)
Barron's favorite stocks for 2012 After a volatile year, stocks are heading into the homestretch about where they began. The benchmark Standard & Poor's 500 Index finished the week at 1255, within a percentage point of where it  (more)
Barron's favorite stocks for 2013 With uncertainty roiling the market, the big question is not, will the market go up next year, but what stocks will go up. Think Apple, Royal Dutch Shell, JPMorgan Chase, and more.
Barron's picks 10 stocks as good dividend bets Barron's Nov 23 edition cited Banco Santander's relative financial strength in a troubled industry as well as its geographic diversity and a 10-year return rate of 9.2 percent, annualized through Oct  (more)
Barrons 10 Tempting Bargains 10 Tempting Bargains. The trouble may not be over, but Barrons found 10 stocks that look irresistibly cheap.
Barrons 12 Stocks for 2008 What did badly in 2007 might do well in 2008, because valuations in many depressed sectors are at multiyear lows. Single-digit price/earnings ratios are common in the financial sector, and stocks in  (more)
Barrons 24 Stocks Worth Buying What bear market? Barrons investments pros find 24 stocks to buy in 2008, in a multitude of sectors.
Included in these recommendations, Barrons recommend to BUY:

DYHOL.Turkey Dogan  (more)
BB&T Capital Mkts BB&T Capital Markets is dedicated to delivering world-class corporate banking, investment banking, and capital markets solutions to commercial clients, corporate clients, and government entities. Our  (more)
Bear Stearns The Bear Stearns Companies Inc. (NYSE: BSC) is the parent company of Bear, Stearns & Co. Inc., a leading global investment banking, securities trading and brokerage firm. Since 1923, we have helped  (more)
Benchmark The Benchmark Company, LLC is a full-service Broker Dealer dedicated to meeting the needs of institutional and private clients.
Operating from offices in New York, Boston, San Francisco,  (more)
Berenberg Berenberg
Bernstein A central advantage for Bernstein clients is the ability to harness our highly regarded expertise in investment research and management. Originally known as a value investor, Bernstein has long been  (more)
BGB Securities BGB Securities
BioLogic Equity Research BioLogic Equity Research is an equity research firm. It focuses its research on healthcare sector including biotechnology, pharmaceuticals, and medical technology. The firm offers event-driven  (more)
BMO Capital Markets The U.S. Equity Research team comprises over 25 analysts located in New York, Atlanta, Boston, Denver, Houston and Los Angeles. We cover more than 375 stocks and also provide equity strategy,  (more)
Boenning & Scattergood Our equity research team concentrates on companies that aren’t widely covered in sectors such as water distribution/equipment/technology, financial services, business services, aerospace & defense  (more)
BofA/Merrill BofA/Merrill
Brean Capital Brean Capital
Brean Murray Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary  (more)
Brigantine Brigantine Advisors is an integrated research team with its first focus on the technology sector. The equity research analysts on our team began their careers in industry with most spending an  (more)
Broadpoint AmTech Broadpoint AmTech
Broadpoint AmTech Research Broadpoint AmTech, Inc. is an equity research firm specializing in research on large and small cap companies. It provides equity research, sales, and trading services. The firm provides fundamental  (more)
Broadpoint Capital Broadpoint Capital, Inc. is an investment banking and capital markets firm that provides corporate and public finance services and trading of corporate, government, and municipal securities for  (more)
Bryan Garnier Bryan Garnier
BTIG Research BTIG Research created one of the most agile and efficient sales trader-crossing networks in the industry. Widely dispersed, we operate as a tightly knit team with a single mission—to leverage our  (more)
Buckingham Research Buckingham Research
Burke & Quick Burke & Quick
Burrill Institutional Research Burrill Institutional Research
BusinessWeek: Top Stock Picks for 2010 For investors, 2009 was a year when hopes of economic recovery sent a wide swath of the stock market higher. Even the market's most troubled companies had shares that doubled, tripled, or even  (more)
BWS Financial · BWS Financial is a Los Angeles based independent stock research firm, which focuses primarily on undervalued companies with little or no street coverage, within the biotechnology,  (more)
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy